Guardant Health GH
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 8th percentile, 5-year average -15.5x
Below its usual level · 27th percentile, 5-year average -117.7x
Near the top of its 5-year range · 80th percentile, 5-year average 10.6x
#4693 of 5161 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | -71.52 | – | -117.66 | 27% (cheaper than usual) | – |
| PE | -39.63 | -60.28 | -15.49 | 8% (cheaper than usual) | – |
| PS | 15.43 | 11.74 | 10.56 | 80% (pricier than usual) | #4693 of 5161 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on GH.
Sign in to join the discussion.